IQV:NYSEIQVIA Holdings, Inc. Analysis
Data as of 2026-09-03 - not real-time
$263.84
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
IQVIA Holdings Inc. is priced at $263.84 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 32.9%. Momentum indicators put RSI at 70.8 (overbought) with MACD reading bearish. The recent range runs from support at $228.76 up to resistance at $266.08.
Multiples put this in overvalued territory: 32.1 times earnings against the sector's 30.8. Analyst price targets sit 4.7% above the current price. Revenue is growing at 8.7% on a 8.1% profit margin.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 47.3%, a beta of 0.78 and a maximum drawdown of 35.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Multiples put this in overvalued territory: 32.1 times earnings against the sector's 30.8. Analyst price targets sit 4.7% above the current price. Revenue is growing at 8.7% on a 8.1% profit margin.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 47.3%, a beta of 0.78 and a maximum drawdown of 35.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
In late July and early August 2026, IQVIA Holdings and Medera announced a collaboration pairing IQVIA’s global...Clinical research company IQVIA NYSE: IQV in Q2 CY2026, with sales up 8.IQVIA Holdings Inc. NYSE:IQV extended its winning streak to a 4th straight session on Tuesday, jumping 13.94 percent to...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- RSI at 70.8 signals overbought conditions
- Trading above the 200-day average of 201.37
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- RSI at 70.8 signals overbought conditions
- P/E of 32.1 versus sector average of 30.8
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 32.1 versus sector average of 30.8
- Return on equity of 22.8%
- Elevated debt-to-equity of 258
Key Metrics & Analysis
Financial Health
Revenue Growth8.70%
Profit Margin8.10%
P/E Ratio32.1
ROE22.82%
ROA5.06%
Debt/Equity257.98
P/B Ratio7.0
Op. Cash Flow$2.8B
Free Cash Flow$2.1B
Industry P/E30.8
Technical Analysis
TrendBullish
RSI70.8
Support$228.76
Resistance$266.08
MA 20$250.60
MA 50$226.78
MA 200$201.37
MACDBearish
VolumeIncreasing
Fear & Greed Index94.29
Valuation
Fair Value$151.96
Target Price$276.28
Upside/Downside4.71%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.78
Volatility47.29%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.